|Products||Imject Maleimide Conjugation Buffer from Pierce Biotechnology, Inc.|
|Company||Pierce Biotechnology, Inc.|
|Item||Imject Maleimide Conjugation Buffer|
|Description|| Pierce offers maleimide activated carrier proteins to simplify the production of hapten-carrier conjugates. Imject Maleimide Activated Carrier Proteins are commonly used carriers that have been preactivated with a heterobifunctional cross-linker (Sulfo-SMCC). This activation results in a stable, sulfhydryl-reactive carrier protein. Thus allowing the maleimide-activated carrier protein to conjugate with cysteine residues on any peptide or protein, making a complete immunogen.|
Save timeno need to preactivate the carrier with Sulfo-SMCC • Conjugation can be performed directly in the vial (because of EDTA in the buffer, gel filtration or dialysis must be performed prior to immunization) • A hapten-carrier conjugate is formed in just two hours • Results in a stable, covalent thio-ether linkage • Purified proteins, activated with sulfhydryl-reactive maleimide groups • Lyophilized in PBS, pH 7.2, containing EDTA
|Info|| Pierce Biotechnology, Inc.|
Pierce Biotechnology, Inc.
3747 N. Meridian Rd.
P.O. Box 117
Rockford, IL 61105
Customer Service: 815-968-0747
Fax Number: 815-968-8148
Web Site: http://www.piercenet.com/